It has been suggested that TNFRSF12A expression is abnormally upregulated in numerous carcinomas, such as colorectal cancer (18), glioma (19), and breast cancer (20), which is closely associated with tumor aggressiveness and patient prognosis. The gene discussed is TNFRSF12A; the disease is neoplasm.